After receiving a positive recommendation from the EMA in 2024, the US biotech company has had its applicatoin rejected by the FDA.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/outlook-therapeutics-plunges-after-rejection-from-the-fda/
关于作者
相关推荐
-
Should I Tell a Candidate Her Career Goals Are Unrealistic?
… and 2 various other challenging office issues …Read More
-
Recycled graphite demonstrates same performance as mined
Vianode and Altilium brag recycled graphite remedies .
-
World’s biggest lithium producer urges state help to compete with China
US-based Albemarle cuts growth intends amidst battles for cpu of vital mineral for electrical automobiles
-
Protecting Your Digital Life: Cybersecurity, Part 1
As designers of business degree software program, we understand firsthand that cybersecurity has actually never ever been more vital. From safeguarding our individual details to se…
